Abstract
There are two mechanisms by which free full-thickness allografts are rejected: an early endothelial and a late epithelial type. These two types occur because there are apparently 2 target cells against which rejection is directed: the endothelial and the epithelial cell. The endothelial appears to be mediated by humoral antibodies and the epithelial by small lymphocytes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
